GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: M7824 | MSB0011359C
Compound class:
Antibody
Comment: Bintrafusp alfa (M7824) is an investigational bifunctional fusion protein that combines two TGFβ 'trap' domains (derived from the extracellular domain of TGFBR2) that are linked to each of the C-terminal domain of the heavy chains of an anti-PD-L1 IgG1 monoclonal (mAb) [1,3]. The antibody component is similar to the anti-PD-L1 mAb avelumab and similarly, bintrafusp alfa was developed as a cancer immunotherapeutic [5]. Based on evidence that both the TGFβ pathway and the PD-PD-L1/PD-1 immune checkpoint are associated with tumour immune evasion, simultaneous targeting these pathways was predicted to control tumour growth by restoring and enhancing anti-tumour immune responses [2,4].
|
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 10665 | bintrafusp alfa |
Synonyms ![]() |
| M7824 | MSB0011359C |
Database Links ![]() |
|
| CAS Registry No. | 1918149-01-5 (source: WHO INN record) |
| GtoPdb PubChem SID | 440816745 |
| Search PubMed clinical trials | bintrafusp alfa |
| Search PubMed titles | bintrafusp alfa |
| Search PubMed titles/abstracts | bintrafusp alfa |